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Introduction
Sustainable agriculture is widely acknowledged as a fundamental component of any strategy to fight poverty and food security problems in developing countries. The World Bank estimates more than 86% of poor people living in developing countries rely on agriculture practices as the source of their livelihood [1] . Agricultural biotechnology has been recognised as a research tool that can potentially contribute to sustainable agriculture in developing countries. Recent reports have shown that agricultural biotechnology (especially genetically modified (GM) crop technology) has made a significant impact in terms of increased yields, increased income and improved quality of life in developing countries [2, 3] . Crop varieties such as drought and herbicide-tolerant, insect and pest resistant traits have been developed using modern biotechnology, particularly genetic engineering. However, there is little or no access to this innovation that has great potential to improve agricultural productivity and sustainable development in developing countries.
One notable problem is obvious in the area of biotechnology research and development (R&D). This problem is the increased intellectual property rights (IPRs) protection which can constitute both a problem and an opportunity for the adoption of agricultural biotechnology in developing countries. The GM crop technology is very expensive and investment oriented with a huge capital base market because biotechnology R&D is largely dominated by private-sector firms [4, 5] . For example, in the US, revenue for the biotechnology industry increased from $8 billion 1992 to $ 25 billion in 2000, an increase of over 300% during this time-period alone [4] . Multinationals placing strong IPRs on agricultural inventions including research tools have affected the development, adoption and diffusion of new innovation in developing countries. As a result, research tools that are needed for the development of subsistence crops are often not available. Some of the research tools used in modern biotechnology such as micro-propagation, marker-assisted breeding, mutation breeding and genetic engineering have produced different crop varieties in use today. These research tools are needed to overcome the inevitable crop production problems due to low yields, postharvest losses, drought, disease and insects in developing countries. Given the IPRs "logjam" that constrains these research tools, there is a need for innovative solutions to tackle food security problems.
The application of open source in software development led to the concept of applying open source in agricultural biotechnology [6] . Open source biotechnology is a method of creating genetically modified crops that does not infringe on patents held by large biotechnology companies. The technique would be made available free to others to use and improve as long as the improvements are also available free. Similar to open source software, the idea is to spur innovation. It is believed that open source will create opportunities through which life science inventions can be made available to the public and broad research communities by effectively opening up the IPRs "logjam" [7, 8] . Open source as an alternative to proprietary technologies is gradually becoming popular in developing countries in the area of information and communication technology (ICT) [9] . Free accessibility and low cost are some of the characteristics that make open source software technologies an attractive proposition to poorer communities [10] . Developing countries are taking advantage of the inherent benefits of open source (e.g. availability of source code, ability to modify and customize the software, lower total cost of ownership, freedom from vendor lock-in, availability of community support, etc.) to solve practical problems in agriculture, health, environment and education to improve livelihood in the rural areas.
In order to use the open source approach, we must understand the role of IPRs with regards to the development of agricultural biotechnology and how open source can increase (or decrease) access to biotechnology innovation in developing countries. Therefore, we ask the following research questions in this investigation:
Q1. What role does IPRs play in limiting access to research tools such as modern biotechnology that has great potential to increase agricultural productivity in developing countries? Q2. What are the relevant examples or case studies of the open source approach that can benefit sustainable agricultural development? Are there generalizable solutions than can be drawn from these cases? Q3. Are there lessons to be learned from existing initiatives to facilitate access and promote open source approach for biotechnology R&D?
The aim of this paper is to provide answers to these questions by investigating the role of open source biotechnology in sustainable agricultural development.
Research methodology
In social and physical sciences research, relying on and integrating data from multiple sources has long been recognized as a standard practice. Triangulation or crossexamination is often used to indicate this research methodology [11] . Triangulation increases the reliability of the data by allowing the researcher to make inferences and value judgement by comparing and contrasting information in one data set against another. In the context of data collection, triangulation serves to corroborate the data gathered from various sources. Furthermore, Denzin (2006) [12] distinguished between four types of triangulation research methods, and pointed out that methodological triangulation (such as the one employed in this research) involves using multiple choices to gather data, such as documents or review of the literatures, observations of initiatives that can add value to what is being studied [11, 12] .
Given the paucity of empirical data linking open source and agricultural biotechnology, especially in the context of developing countries, qualitative methodological approaches are the most appropriate for synthesizing evidence from various sources, increasing confidence in the interpretation of research results, and enabling the results to build or propose frameworks (such as the Open Source Biotechnology Framework-OSBF) which may help others to undertake research in this area.
In our first data source, the literature and best practices review provided an overview of this field of study but also may increase our understanding of the sustainable aspects of agricultural practices in developing countries. The second data source, the case studies, helped us to find out why open source can be a valuable tool in overcoming the IPRs logjam, facilitating access to information, and mitigating risks. The main reason for using case studies as research instruments is grounded in the argument by Yin (2003, p111) [11] , that a case study design should be considered when "the focus of the study is to answer how and why questions" and when the researcher wants to "cover contextual conditions" which are believed to be relevant to the phenomenon (agricultural biotechnology) studied. Thus, a case study approach was chosen for this research. In the third data source, we contrast four prominent initiatives that promote open access to agricultural and health biotechnology innovations.
The rest of the paper is structured as follows. Section 2 introduces background and work related to our research, and describes the principles of open source and how the concept of open source software is similar to traditional farming practices of free sharing and exchanging of seed. Section 3 discusses the implications of IPRs and demonstrates relevant examples of tools used by the IPRs system in agricultural biotechnology. Section 4 examines potential benefits and the impact of open source on agricultural development. This section also demonstrates examples through case studies and initiatives promoting agricultural biotechnology innovation. Section 5 examines the constraints associated with the adoption of open source biotechnology and proposes an Open Source Biotechnology Framework (OSBF) with policy implication towards advancing agricultural development. Finally, the paper concludes with a summary of critical issues for open source biotechnology development.
Background
The term open source was first used in free software development [13] . Free open source software (FOSS) uses free software and open source which is licenced to use, copy, modify, redistribute and gives the opportunity to increase the value of software or technology to a desired taste or for different purposes with the full access to the source code [6, 14] [17] . The idea of the copyleft licence is to ensure that everyone has free access to the innovations without further restrictions. However, enhanced value of the technology can still be converted into economic benefit just as in the case of proprietary technology, but at the same time it must be freely offered to the public [18] . The concept of open source is, however, a matter of liberty not necessarily production cost as there are typically no costs evaluated toward labor even though the process is labor intensive.
Therefore, one should think of "free speech", not "free beer" when understanding open source software [19] . The increase in the value of investing in the time and labor for open source technology is in downstream cost savings. In science, this can be in the form of a research tool that was reproduced and improved leading to a high quality product through open source development. This would make the research tool available to the community at no cost, increasing the opportunity for more innovation through broader access.
Over the past decade, the awareness of open source is increasingly growing worldwide. The open source principles hold substantial promise for developing countries particularly in the area of biotechnology (e.g. agriculture, health). Due to the mode of operation and the benefits associated with open source, different initiatives are being deployed across different fields, promoting the use of open source for the benefit of the society. This idea has led to numerous innovations in terms of operating systems and products. The free open source operating system (GNU/ Linux Software) as first initiated by Linus Torvalds [16, 20] has made a significant impact in promoting open-source development and many initiatives have followed this example. Some of the initiatives using open-source and 'copyleft' approach for their research tools include: The International HapMap project for mapping haplotypes of human genomes [8] , computational drug discovery and developments for treating tropical diseases by Tropical Disease Initiative [21] , biological R&D by the Open Bioinformatics Foundation [22] , advanced genetics for improving agriculture and sharing biological innovations in poor communities by Biological Innovation for Open Society [7] which is founded by Centre for the Application of Molecular Biology to International Agriculture [23] called CAMBIA BiOS Initiative.
Agricultural innovations are widely known as the key driving force for rural development in developing countries. And farmers play a vital role in the development process of innovations but are faced with problems of insects and pests, low income, small yield products, lack of communication and other technological problems in developing countries. Some of these problems are partly due to multiple intellectual property claims on key inputs and tools used in agricultural biotechnologies. Because of these factors, and the need for innovation to be more affordable and become more decentralized, the open source development presents an alternative distributive model in technological development for agricultural innovation.
Moreover it is possible that some version of open source software may be directly relevant to agricultural R&D. An example was given by some authors in the case of the seed industry relating the event to computer software in the 1970s [24, 25] . Douthwaite and Srinivas (2002) [24, 25] observed that it was a traditional practice for computer programmers to freely exchange code among themselves which was similar to farmers that shared seeds freely with others for growing, improving, saving and reproducing crops. These days, a very different model has emerged where private companies in software and agriculture lead innovation which limits this older practice of free sharing. 4 FOSS Bazaar is an open community of technology and industry leaders that collaborate on how to accelerate the adoption of free and open source software in the enterprise as well as focussing on best practices, education and tools (https://fossbazaar.org/). 5 Creative commons recommends and uses free and open source software licences (General Public Licence-GNU) for software development (http://creativecommons.org/software). 6 Copyleft is a word used to describe the practice of using copyright law that allows distributing copies and modified versions of work and granting the same right preserved in modified version of the work.
As discussed in this section above, an open source mechanism called copyleft was developed so that any innovation resulting from the open source approach would not be protected or stopped from copying or modifying either by the original licensor or his licensees under open source licence [26] . The same copyleft approach will be applied in agriculture where innovations are developed and allowed to be shared freely among the innovators as bound by the rules and agreement of open source licence for further improvements and distributions without any obstacles. Through this method, open source biotechnology can play a significant role in future agricultural development especially in seed industries that have been dominated by multinationals restricting access to the distribution of seeds through the intellectual property rights (IPRs) system. Based on these practices and the initiatives described above, we define open source biotechnology in this investigation as the development and maintenance of agricultural practices and research tools that allow both producers (e.g. companies) and consumers (e.g. farmers) to actively participate in the development process and freely reveal and share their innovations.
The implications of IPRs for agricultural biotechnology
Intellectual property rights (IPRs) are a set of laws that confer exclusive rights on inventors or products of inventors for a given period of time [27] . The role of IPRs became prominent in the protection of plant varieties in the second half of 20th century [28] . The assignment of IPRs to plant protection first took place in United States (US). When the vegetable propagated plant was patented in 1930. Prior to this event, traditional farming was mainly based on freely exchanging, saving, collecting and replanting seeds among the farmers. But the introduction of IPRs, particularly for agricultural research tools and databases through different patenting systems has led to the expression of concerns among different communities such as farmers, universities, plant scientists, industries, and governments particularly in developing countries. The concerns are based on agricultural innovations being hindered through introduction of IPRs that interferes with traditional farming practices. This section will focus on the implication of IPRs for agricultural biotechnology with relevant examples, while examining the role of patents, terminator technology and freedom to operate innovative technology.
The role of the patent in agricultural biotechnology
The existing intellectual property rights (IPRs) relevant to agricultural biotechnology are complex [29] . Most of the international agreements focus on different aspects of agricultural IPRs that are governed by different sets of rules, guidelines and policies. For example, the International Union for the Protection of New varieties of Plants (UPOV) focuses on protecting the right of seed producers (e.g. commercial plant breeders). The Convention on Biological Diversity (CBD) focusses on protecting the rights of farmers using landraces. The Traded-Related Aspects of Intellectual Property Rights (TRIPS Agreement) of World Trade Organisations (WTOs) works specifically on strengthening the rights of inventors [30] .
However, when these organisations are expected to work together towards a common goal, international changes in the IPRs system sometimes cause failure to deliver. For example, UPOV was established by six European nations in 1961. And it was subsequently revised in 1972, 1978 and 1991. The emergence of UPOV in 1961 triggered approval and passage of the Plant Variety Protection Act in US in 1970 [31] . The difference in policy and guidelines between North America and Europe which led to the change [32] , helped prevent access to informal exchange, as well as farmers saving and replanting of seeds through the enforcement of law. This is in sharp contrast to the original UPOV that allowed breeders to exchange or sell their seeds by member countries [33] .
At the same time, the current international environment for IPRs adds to the complexity of the IPRs regime because there are multiple entities representing different interests and processes. The lack of coherent international agreements has created loopholes for agricultural IPRs, particularly in the area that relates to agricultural biotechnology, therefore creating more opportunities for multinationals to exploit loopholes in legal agreements with developing countries [29] . For example, CBD was criticised for not recognising the IPRs agreement within the context of TRIPS. In fact the TRIPS agreement undermines the role of CBD in conserving biodiversity and managing genetic resources. Typically, law is being enforced through collaboration between national and international institutions on a global scale. Furthermore, the developing countries are under obligation in line with the TRIPS agreement for the protection of plant varieties either by patent or by other means of the IPRs system [29] . This agreement was done without necessarily considering its beneficial effects on consumers or producers and its possible impact on food security in developing countries. However, the UN Food and Agriculture Organisation (FAO) played an important role in reaching a positive agreement for developing countries in the International Treaty on Plant Genetic Resources for Food and Agriculture [34] .
The issue of IPRs became even more challenging when two independent events took place in the US the same year. These events were pivotal for innovation in life sciences: the legislative approval and implementation of the BayhDole established Act of 1980, and Supreme Court decision in favour of patent protection on genetically modified organisms in the landmark Diamond v. Chakrabarty in 1980 [35] . After this remarkable development, a series of events followed, in the US and across Europe where large investments were made in agricultural technology in the private sector in collaboration with the universities. Modern IPRs regimes (patent regimes) have been heavily criticised by some due to non-disclosure of many innovations that can benefit the public. The US is arguably the largest world patent portfolio. The total number of patents analysed between 2002 and 2009 was 7469 [5] . Of these figures, the US accounts for 5, 690 filed under the US Patent and Trademark Office (USPTO) while 1779 were filled under the European Patent Office (EPO). The annual trend in crop biotechnology patents is shown in Fig. 1 . The patents related to the cultivars were only patentable at the USPTO which suggests that the US controls agro-biotech markets due to the large R&D investments [5] .
The private sector is mostly involved in biotech industries and makes extensive use of IPRs in form of patents [5, [36] [37] [38] [39] . Multinationals such as Monsanto, DuPont, Syngenta and Bayer are famous for acquiring large number of patents with more than 70% of the patents in agricultural biotechnology in between 2002 and 2009 [5] . About 80% of biotech patents under the cultivars category can be attributed to three of six integrated major multinational companies (Monsanto, DuPont and Syngenta). According to Jefferson [37] , Monsanto alone has a patent application for over 460,000 genes which is more than 10 times the number in any plant species. Some of these biotech companies have large markets in developed countries with a strong IPRs on cash crops (corn, cotton, and soybean) through patent. The lack of free access to innovative tools was largely responsible for the slow development of genetically modified (GM) crops with herbicide tolerance traits according to American Cyanamid [38] . In addition, multinationals mainly concentrate on crops of primary interest which will result in the largest financial benefit derived from cultivating these crops, therefore neglecting the innovation needed to develop "orphan crops" 7 that are simple and cost effective for poorer countries. This is consistent with the argument raised by Parayil (2003) [39] that certain crops are developed to increase shareholder value for private companies as opposed to solving the problems of hunger and deprivation in developing countries. The issue of ''patent thicket'' arises when there are numerous negotiations involving high transaction cost and uncertainty with different patent holders [40] . The resulting transaction cost limits innovations. According to Isaac and Walter (2004) [41] , economists refer to the need for such negotiations under the general rubric of "transactions costs". The most famous example is "Golden Rice" which has experienced a lot of delays due to a patent thicket of about 40 contractual obligations that initially caused the Golden Rice project setback [40] . Golden Rice was a biotech innovation that could potentially solve vitamin-A deficiency problems in developing countries where millions of young children were dying of malnutrition. It became a "bone of contention" among more than two dozen biotech companies claiming the patents. Golden Rice saga demonstrated that multiple owners holding overlapping and fragmented IPRs to different components of a large innovation can be a problem for developing and disseminating innovation. Academic researchers are affected when there is high transaction cost on a wide range of innovations. Their research becomes more difficult when there is uncertainty as to whether they might infringe company patents, sometimes regarded as "research exemptions" without seeking licences [42] .
This has led to questions of whether enforcement of patent rights stand in the way of basic research in universities. Genetech argued that open science was being encouraged without enforcing patent rights on research tools [43] . This is in contrast to arguments presented by Eisenberg which was based on high transaction cost for acquiring proprietary research tools that involved many different institutions [44] . Two cases cited by Eisenberg include patent research tools such as rDNA and polymerase chain reaction (PCR) of Cohen Boyer and Hoffman La Roche respectively. Eisenberg (2002) [44] further argues that strong IPRs on research tools lead to reduced innovations and underused knowledge that creates rights of exclusion (anti-common) by IPRs holders. An example of the expressed sequence tag (EST) was given, a situation where some groups attempted to patent EST but abandoned this due to resistance from other competitors. This view suggests that once there is patent lock on innovative tools it creates a logjam in health and agriculture, development worldwide [37] .
While Eisenberg and others presented some evidence with regards to the argument that patents create less innovation and adversely affect R&D [35, 44] , some literature has argued that patents enable collaboration and facilitate negotiations between research tool users and producers leading to development [45] [46] [47] .
What role can 'terminator' technology play?
One of the primary purposes of intellectual property rights (IPRs) in biotech industries is to gain profits through the application of patenting, temporarily allowing companies to have a monopoly on certain innovative technologies, particularly in agricultural biotechnology. This is demonstrated by the revenue generation trajectory of biotech firms where plant patents that are held by private firms situated in developed countries generate revenue from the poorest for multinationals in the wealthiest countries [39, 48] . With the development of new plant varieties by these companies, a different strategy is devised where IPRs cannot effectively serve their intended purpose. The use of [5] . 7 Orphan crops are a diverse set of minor crops such as millet, yam, cassava, cowpea, sorghum grown by poor farmers. These crops are not traded around the world and also receive little or no attention from research networks but play an important role in regional food security.
terminator technology has the potential to circumvent this problem. The word 'terminator' was coined by activist groups in an attempt to ban the use of sterile seed technology [49] . The original name is called Genetic Use Restriction Technologies (GURTs). GURTs were granted US patent (5,723,765) in 1998 to joint partnership between U.S. Department of Agriculture (USDA) and Delta & Pine Land Company (the U.S. biggest company supplier of cotton) for the two types: trait-specific (T-GURT) and variety-level (V-GURT) [50] . While T-GURT is designed for GM trait-specific (e.g. disease resistance), V-GURT is designed for GM crop varieties through seed sterility [51, 52] .
The terminator technology is mostly targeted at developing countries where IPRs are non-existent and terminator technology may not have much effect on developed nations as other technologies can be used to unravel and relocate innovative characteristics for plant breeding [53] . The idea of introducing terminator technology is not only to protect IPRs and stimulate private R&D but to prevent the flow of unwanted genes from genetically modified (GM) crops, and to help solve plant-back problems in GM crops [52, 54] . According to Eaton et al., (2002) [52] , the implementation of terminator technology can potentially lead to a reduced atmosphere for sharing genetic resources through increased IPRs protection, particularly among competing companies and institutions. In developing countries, poor farmers may not be able to afford GURT seeds from suppliers every year and also may limit their ability of saving and exchanging seed practices. And Monsanto may sue farmers that save and reuse their seeds. For example, an infringement suit was brought against a farmer that saved 1500 bushels of Bt soybean seeds from his field enough to grow 1500 acres another year [55] . This approach may discourage poor farmers from buying patented seeds. Moreover, traditional crops may suffer reduction in viable seed production from sterile GURT seed technology due to pollen transfer [56, 57] . Although, it may be possible that the so called T-GURT form of what is referred to as terminator technology would serve a good purpose in terms of disease resistance [58] , saving and replanting the seeds (excluding transgenic traits) but farmers will have to pay for activating chemicals each year [59] . Given little or no detailed application of V-GURT in the literature [60] , more evidence-based scientific research will need to be done, but the opportunity may not exist in the future as the terminator technology kind of approach in agricultural biotechnology is widely opposed. For example, as a result of wide-spread criticism of terminator technology (V-GURT, in particular), the application of V-GURTs for different varieties was disqualified in India [51] and was rejected by the Rockefeller Foundation [61] and by the Consultative Group on International Agricultural Research (CGIAR) [62] . Given this opposition, it may be difficult for GURT technology to replace IPR in developing countries.
Freedom to operate innovative bio-technology
Open source has become an important mechanism to deliver free access in a global market for public goods such as innovative bio-technology. When monopoly rights are conferred on innovation, it narrows the field of innovation, particularly in the areas critical for the public goods (such as genetic resources for agriculture). The problem is that government funding for R&D is far less than private sector funding meaning that the profit motive becomes a priority. While this drives technological innovation and economic development in many instances, in some instances it can inhibit the diffusion of innovation. For example, when a company or institution invents a technology, a patent is usually filed so that such invented technology is protected from free use. In most cases, the company prevents exclusive use of technology to regain any investment made on the invention for about 20 years when the patent would have run out [63] . [64, 65] . Given this challenge, efforts should be increased for the involvement of country government, private sector and international organizations to facilitate and encourage freedom to innovate where access is limited to biotechnology R&D, particularly in developing countries.
The researchers at the universities or academic institutions find it difficult to use research tools that could lead to more innovations due to associated risks, particularly in the light of patented technologies, while advancing their research work. Some literature evidence suggests that researchers are experiencing difficulty, delay and redirecting of research due to the high cost and problem of accessing permission to patented technology that can benefit research programs [66, 67] . Even though, this kind of problem often happens in developed countries, without doubt, it becomes a spill-over problem when the technologies are transferred to developing countries [68] . According to Hoekman et al., (2004) [68] , the improvement that occurs at a rapid rate may not be located in another industry without the policies for the productivity improvement that depend on a country's own R&D. When this problem occurs, freedom to operate becomes a difficulty due to a lack of easy and quick access to material held by others. Again, the cost of freedom to operate may be too high for public institutions to afford [69] . Additionally, the use of IPRs as constraining innovation is seen as a problem in universities and in developing countries. Most significantly it can be a serious threat to the supply of food due to the problem of access to IPRs as expressed by the international research and donor communities [70] .
Potential benefits and impacts of open source for agriculture and biotechnology
The role of information and communication technology (ICT) in improving the quality of life in rural areas of developing countries is fast gaining recognition [71] . The benefits of open source innovations are common in many areas of ICT for educational, social and economic activities around the world. Now, open source has started to benefit agricultural practices in developing countries for improving agricultural productivity and providing better communications within farming communities that connects farmers to the rest of the world. This kind of open source innovation will provide opportunities for farmers to increase their knowledge on best farming methods, provide relevant information on agricultural inputs (e.g. fertilizer and seed), weather, storage and other farming activities, and widen their markets and gain new customers without internet connection, particularly in the rural areas [10, 72, 73] .
Apart from the examples demonstrated in the Table 1 , there are several other initiatives being implemented through Open Mobile Consortium in developing countries particularly in Africa to facilitate access to information between non-governmental organisations (NGOs) and small farmers in the rural communities. For example, the United Nations Children's Fund (UNICEF) Innovation has created an open source platform called Rapid SMS to monitor food distribution in Ethiopia and to assist in improving process of tracking the nutritional trends of Malawian children [73] . Frontline SMS is another open source platform that provides free access to software that is being used mostly in developing world in the area of agricultural development [74] . The biggest impact of Frontline SMS has been recorded in Philippines, Nigeria, India, Malawi, Pakistan and Kenya. For example, in Kenya, Frontline SMS facilitates and increases access to sales and deliveries as well as providing more accurate price, quality, and quantity information among small farmers and medium-size retailers. The ICT sector unit of World Bank group has described several mobile applications for agriculture and rural development (m-ARD) that can be made available via open source in developing countries [75] . For example, m-ARD applications are under detailed case studies for agriculture markets and extension services and these applications are active in many developing countries including India, China, Philippine, Colombia, Argentina, Uruguay, Tanzania, Uganda and Kenya. Although many of these mobile applications are pilot studies they still hold promise for advancing future agricultural production and enhancing food security in developing countries.
While the impact of Frontline SMS is growing in health and agricultural development [74, 76] , effort is required in the area of ICT education which is the key to successful adoption. Qiang et al., (2011) [75] emphasised that the private sector, the public sector and donors must increase their efforts by improving the infrastructure, training young professionals and opening up access to publicly available data to facilitate development of mobile application.
Biotechnology is another field where open source has great potential to contribute to agricultural development. Open source biotechnology may be key to knowledge and innovation for agricultural development, and part of the solution to the increasing population problem in developing countries. Given the patent impediments on new agricultural innovations, different initiatives are emerging To facilitate multi-stakeholder partnerships and services among farmers, extension officers, scientists and other organisations for free agriculture knowledge sharing.
[ 78] through open source development to facilitate access to modern agricultural biotechnology. [79] , as described in the Table 2 .
Efforts by the CAMBIA BiOS initiative (Table 2) are not just about the campaign or creating awareness, but they demonstrate practical examples of donating free technologies through open source licencing. Of all the initiatives, the BiOS initiative under the leadership of Richard Jefferson is arguably the most useful for developing a framework for agriculture and has been at the forefront of promoting open source for sharing biological innovation [83] . For example, the GUS reporter system arguably remains the most widely used staining technique in plant science with over 4000 literature citations. Two different academic institutions have benefited from using open source research tools for carrying out experimental research in agriculture [84] . The scientists at Cornell University in collaboration with a Hawaiian Papaya Growers Co-operative (made up of a small group of farmers) used CAMBIA open source research tools to find a solution to a virus problem in papayas. The second example of use took place at Huazhong University where more than 20,000 unique lines were created by Zhang Qifa, a leading Chinese scientist in plant biotechnology.
However, the Public Intellectual Property Resource for Agriculture (PIPRA) can be distinguished from opensource as they have different approaches for sharing Table 2 Initiatives promoting open access to agricultural and health biotechnology innovation. Source: [8, [79] [80] [81] [82] .
Initiative
Major areas of activity (TransBacter system). GUS reporter gene system has been a mainstay of plant biotech research that led to the first release of transgenic potatoes in 1987. The Patent Lens is a platform to focus, understand, and investigate the patent rights and to inform practitioners and policy-makers. It is a free full text searchable database for intellectual property informatics and analysis containing over 1.6 million patents in the life sciences. BioForge is an online interface where enabling technologies is made available via creating and distributing key "pump-priming".
Creating an innovation where IPR or patent restricts free access to diagnostic technology can be a useful tool to solve farming problems under BioForge open-source initiative. Since its establishment, efforts have been geared towards a strong campaign to provide communicative systems that allow dispersed individuals to participate and benefit from decentralised innovative research. PIPRA The Public Intellectual Property Resource for Agriculture (PIPRA) involves a group of non-profit institutions from more than 15 countries around the world with focus on intellectual property issue (e.g. patent) by providing free access to patented technology, particularly agricultural biotechnology under a set of shared principles. PIPRA membership is open to any university, public agency, or non-profit research institution actively engaged in research and development, but subject to supporting PIPRA's mission and agreeing to the terms laid out in the PIPRA Memorandum of Understanding (MOU). A concerted effort has been made to develop a database of 6600 agricultural patents involving 45 different countries. PIPRA's goal is to ensure farmers, researchers and other organizations are provided with right resource for clarity and analysis of patented technology through effective implementations. PIPRA acts as a resource for technology transfer programs, and for scientists that work in the public sector, to facilitate the transfer and adoption of their technologies. Part of their goals is to mobilize and encourage innovative technologies among various institutions for the development and distribution of subsistence crops based on humanitarian purposes in developing countries. AATF The African Agricultural Technology Foundation (AATF) is an Africa-based non profit organisation that negotiates and facilitates for the delivery and access of appropriate proprietary agricultural technologies to smallholder farmers in Sub-Saharan Africa. AATF engages in public/private partnerships to facilitate sharing and transfer of technology and research products that will benefit African resource-poor farmers without access constraint. For example AATF obtained a royalty-free Monsanto GM technology, a Bacillus thuringiensis (Bt) gene (cry-1Ab) and sublicensed it to the Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) and Nigerian-based International Institute for Tropical for Agriculture (IITA) for the development of pod borer resistant cowpea crop. When the GM cowpea is ready for use in future, the biotech product will be made available through the commercialization and public institution for humanitarian use.
International
HapMap project
The international HapMap project was originally launched in October 2002 to create genome wide database of common human sequence variation from population with ancestry parts of Africa, Asia and Europe. The goal of this project is to store and share data, and make the information freely available in the public domain. The consortium is composed of scientists, funding agencies, public and private organisations from six countries; the United States, Japan, Canada, China, Nigeria, and the United Kingdom. The aim is to enable researchers to find genes that affect health, disease and responses to medications that will lead to development of diagnostic tools.
innovations. PIPRA offers services in terms of collaboration with institutional members on intellectual property policy analysis, biotechnology resources, and commercialization strategy to improve and develop shared technology packages [81, 85] . In open source, service is focused on cumulative improvement which requires downstream transfer of the open-sourced materials under a copyleft style "grant back mechanism" (licensees must agree to share back and allow the right to re-use improvement made on research tools under open-source licence) [86] . While both initiatives differ in a way, they serve the research community well and achieve their purpose of encouraging and sharing innovation by creating more free access to research tools that can benefit various institutions across different countries. While the African Agricultural Technology Foundation (AATF) and the International HapMap project are under different pilot phases, there is a need to encourage a wide range of stakeholders in private and public sector to increase their commitment so as to make it a reliable and effective open source biotechnology operating system.
Challenges in open source biotechnology adoption and the proposed solutions

Constraints in adopting open source biotechnology
As demonstrated above, open source biotechnology has potential to benefit human development, but there are fundamental challenges that must be properly addressed to ensure that open source delivers on its potential. Even though challenges will vary from country to country, most challenges will more likely be faced in developing countries largely due to the high level of poverty, political instability, economic instability and limited resources. Moreover, the challenge of open source adoption will remain a global problem as long as the majority of the world population has little or no access to it. The challenge in using open source biotechnology will not only be in the area of agriculture practices but in every aspect of biological innovation.
Introducing open source biotechnology in developing countries will require a considerable amount of training. Where there is a fair amount of knowledge of ICT, some amount of retraining may be required. For example, AgriBazaar (Table 1) , using FOSS tools in Malaysia were difficult due to the lack of familiarity among software developers. Some of the engineers are used to proprietary software products, and similarly it will take time to adjust to a new product in agricultural biotechnology. Also, the interoperability problems may cause reluctance among the users where organisations need to change to open source [10] . In many places in developing countries, particularly in Africa, the lack of basic infrastructure such as communications and electricity may delay the application or adoption of open source biotechnology. For example, high-bandwidth Internet access is lacking in universities and research institutions coupled with an erratic supply of power. This can limit the ability to participate in open source projects. Furthermore, factors such as a shortage of IT professionals and the absence of IT industries in developing countries can delay the open source development. Each of these cases requires enormous finances for training and retraining processes, and constructing new infrastructure for IT purposes.
The challenge of IPRs is arguably the most complex due to the high cost involved. In the case of resource-poor farmers, an open source consortium that requires IPRs to protect farmer's resources can be very expensive to obtain and maintain, and this may be a big burden to farmers that have limited financial resources [87] . In spite of the fact that the general open source licence policy is based on the promise to keep source code free and allow free access to copyright-protected aspect of the code, challenges still remain in open source biotechnology. There are challenges of the translation of open source software model to biotechnology due to different characteristics governing the patent versus the copyright laws. To achieve protected common access (allow users to access) in open source, copyright as the dominant IPRs licence is the key legal right access in open source software, whereas patent is the dominant IPR form of protection open source biotechnology [20] . In terms of standards, "patentability" is a much higher standard than the "copyrightability" [88] . The cost of getting patents for the innovations in biotechnology can be exorbitant and time-consuming, compared to open source software that costs little and requires less time. Thus, patents can cause a setback in research and limit the experimentation by scientists or individual farmers. In addition, the research culture in open source software is different from open source biotechnology [26] . For example, the equipment used in biotechnology research is very expensive, when compared to software technology that requires a computer and a desk. Considering these factors, the open source approach would be more difficult to diffuse or move quickly in biology than in software.
Patent misuse through grant back mechanisms is another challenge in open source biotechnology [89] . As the technology advances, it may be difficult to keep the research tools and inventions within the confines of open source arena as technology becomes available to the wider research community. For example, in an attempt to seek rewards or compensation for any kind of improvement made to the technology, it may result in legal proceedings if the innovator involved feels that improvement made to the technology should attract greater rewards [89] . Under normal principles of patent law, inventors making novel improvements to the core technology are entitled to apply for patents as long as the requirements of patentability are met and the right improvements are followed. Therefore, the open source licencing agreement may be ignored by the inventor if there is greater reward. This can sometimes lead to shrouded or overlapping rights on research tools among multiple parties. The issue of the grant back mechanism as related to the open source licence may discourage collaboration that would facilitate ideas among young generations of scientists towards increasing creativity and better innovations. For example the grant back mechanism and BiOS viral licence have led to the rejection of BiOS licencing terms for the PIPRA project [90] . Moreover, in the context of the grant back approach, researchers who are interested in commercializing their research work could decide not to participate when confronted with the policy and process for commercialization.
Agricultural biotechnology framework and policy implications for open source development
Proposed open source agricultural biotechnology framework
Based on the analysis of the case studies and initiatives presented, an Open Source Biotechnology Framework (OSBF) shown in Fig. 2 is proposed as a possible solution for the adoption and promotion of agricultural biotechnology R&D for sustainable development in developing countries. Using a similar principle to the open source software development process [6] , the OSBF identifies agricultural biotechnology research and cooperation priorities which are highly dependent on technology for their effective implementation. As shown in Fig. 2 , two developing countries (A and B) working on the same or similar biotech products (e.g. maize or sorghum) can leverage the principle of open source software development and openly collaborate in their R&D activities. According to this framework, agricultural extension workers, research institutions, farmers, governments and other stakeholders can freely and collectively leverage the expertise of biotechnology developer and user bases. They can also benefit or learn from other biotechnology companies and vendors of the software who are willing to reveal and share their innovation, share their experiences and risks, associated with a particular agricultural product. This kind of intra/inter research and collaboration can even be extended to other countries or forms of international alliances where open source biotechnology research and innovation networks are already formed.
Benefits associated with this research and innovation network may include reducing or sharing costs and risks on: (1) communities in various local languages [10] . This can facilitate the acceptance and participation among the targeted group at grass-roots levels. Moreover, training should be provided regularly in the course of the evaluation and adaptation process. Where necessary, retraining should be provided for sustainability and continuity. [91] . Other examples [92, 93] similarly show that open source is relatively inexpensive and easily adapted to local needs for various purposes. This is in sharp contrast to proprietary vendors that are globally profit-oriented with little connection to local needs [94] . Therefore, the government's policy should recognise the importance of FOSS and address the issues concerning the provision of right resources and allocation of budget for the development of open source project.
Collaboration and network expansion.
Collaborative data sharing should be encouraged among the academic communities particularly in developed countries, as this will provide opportunities for researchers in developing countries to benefit. Most researchers in developing countries depend on scientific data and publication from developed countries to advance research in their areas. For example, developing countries have created successful science policies through a two-way contribution of international scientific exchange [95] . Therefore, collaborative data sharing, through open source is one approach to encourage scientific networking between scientists in developed and developing countries. Moreover, collaboration based on common tools where individual sharing of discoveries in biological innovation could be encouraged between universities and multinationals, paving the way for open source biotechnology.
Effective policy and legislation.
The success of open source development requires that effective policy and legislation be developed and implemented in developing countries. Given the importance of political support, it can facilitate processes and increase the adoption rate if there is a high level of commitment. Therefore, government should formulate policies that encourage open source development and the policy should focus on the following areas:
Support of ICT in education and the government sector at all levels; Enabling an environment for the accessibility of ICT by citizens, business and the government; Providing local professionals with adequate training and acquiring skills in relevant software development to remain viable in a competitive market; Identifying and prioritization areas of need such as local software development and IT industries; Adopting open standards for storage and preservation of data.
In addition, governments should work in conjunction with international agencies such as CBD, TRIPS and UPOV to create a friendly IPRs system that will encourage open source development for innovative technologies in developing countries. This can decentralize patented technologies and make them freely accessible to researchers in developing countries, particularly in agriculture biotechnology.
Flexible licencing policies.
Open source licencing policy should be flexible enough to allow interested party to use innovation under the freedom of choice. For example, it should be practiced under the "four freedoms of choice": 1) Access without restriction; 2) Availability of source code; 3) Improve and add to the source code; 4) Redistribute the source code and software. The availability of genomic databases through bioinformatics provides flexibility for the terms chosen by the users. By contrast, biotechnology research does not usually provide an avenue for freedom of choice. Also, the current licencing policy of BiOS does not encourage freedom of choice due to the grant back mechanism [89] . BiOs allows users to refrain from the grant back improvement if kept as trade secrets where it prevents their improvement from being disclosed to another users. A recent report emphasises the fact that an enhanced open source model through a trade secret could offer a flexible policy agreement as proposed for the HapMap project [96] . In addition, a business-friendly licencing policy that will maximize the growth potential of open source biotechnology should be encouraged among the users. Encouraging flexible licencing policies under the open source approach could lead to the rapid development of research tools and increased economic benefits for users in developing countries.
Conclusion
The open source paradigm as applied to agricultural practices has the potential to compensate farmers for contributing to the growth of plant resources, and may serve as information resources for farming communities [87] . While this article discusses the complexity of IPRs in agricultural biotechnology, it also mentions the potential benefit and impact of open source in agricultural and biotechnology development. Addressing the three research questions posed in a systematic way provided insight into the development of open source biotechnology in developing countries. Most importantly, the analysis of specific case studies and initiatives led to the proposal of an Open Source Biotechnology Framework (OSBF) that can facilitate development of biotechnology R&D, exchange of skills and ideas and collaboration among agricultural research institutes between different countries as well as policy recommendations to foster open source development in agriculture.
The adequate provision of basic infrastructure and financial resources will play a vital role in the adoption of open source biotechnology. Education forms the basis through which open source development can be promoted among the citizens, therefore quality education on ICT programs should be provided to encourage wide participation from the grass-root levels. The lack of political support due to a low level of awareness among the government officials on open source in developing countries can slow down open source development. Therefore, a concerted effort should be made to educate and encourage government officials in all relevant institutions. Given the impact of IPRs in creating a research environment for biotechnology, the IPRs system must be designed in a research-friendly way, particularly with regards to protection under law that will facilitate commercialization and technology transfer to developing countries. Added to this, institutional and legal frameworks must be established and encouraged to protect IPRs in developing countries so as to enhance the economic benefit of open source biotechnology products.
While this article has reviewed the existing literature with relevant information about the adoption of open source biotechnology in agricultural practices, not many initiatives or organisations are advocating for open source development for innovations that can enhance sustainable agricultural development. More effort is required from a variety of actors including the private sector, individuals, national governments and international agencies to support and promote open source biotechnology for sustainable agricultural development in developing countries. Moreover, a lot of work needs to be done in terms of further case study analysis to more fully assess the major areas where open source is being adopted, as well as the benefits and the constraints that are associated in open source adoption in developing countries.
Finally, if the introduction of open source biotechnology is to contribute to sustainable agriculture in developing countries, enabling environments must be put in place that include policy formulation and implementation for establishing, supporting and providing the capacity building and resources required to develop open source. Moreover, the attention and focus of open source development should not be restricted to one area but it should address other needs such as health and the environment. The opportunities offered by open source biotechnology can make a significant impact on sustainable agricultural development through free access to modern biotechnology techniques. Open source biotechnology is making slow but steady progress in agriculture, but many issues will have to be addressed to enjoy the benefits of this new innovation in developing countries. This article has raised important concerns that will lead to further debates among stakeholders including scientists and policymakers.
